A major British study has added to the evidence that hormone replacement therapy increases the risk of breast cancer, especially when women receive a combination of estrogen and progestin.
Hormone replacement therapy that combines estrogen and progestin doubles a woman's risk of breast cancer, a British study of more than a million women has found.